Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents. 2013

Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
School of Medical Engineering, Hefei University of Technology, Hefei, PR China.

Three series of novel resveratrol amide derivatives (1a-q, 2a-h, 3a-l) were synthesized and evaluated for their biological activities. All compounds were characterized by (1)H NMR, (13)C NMR, MS and elemental analysis. Furthermore, compound 3e was also characterized by X-ray crystallography. All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line. Among them, compounds 1c, 1g and 3e displayed the most potent COX-2 inhibitory activity with the IC50 values of 1.02, 1.27 and 1.98 μM, respectively. Molecular docking studies were performed to position compounds 1c and 3e into the active site of COX-2 to determine the probable binding modes.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene

Related Publications

Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
August 2009, Bioorganic & medicinal chemistry letters,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
January 2015, Steroids,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
June 2016, Chemical & pharmaceutical bulletin,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
January 2009, Bioorganic & medicinal chemistry letters,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
March 2020, Bioorganic chemistry,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
June 2013, European journal of medicinal chemistry,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
August 2018, Molecules (Basel, Switzerland),
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
July 2018, Acta pharmaceutica Sinica. B,
Ri-Sheng Yao, and Xiao-Qin Lu, and Qiu-Xiang Guan, and Lei Zheng, and Xiang Lu, and Ban-Feng Ruan
December 2016, Archiv der Pharmazie,
Copied contents to your clipboard!